Histamine H3 receptor antagonist
This page covers all Histamine H3 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H3 receptor, H3 receptor (histamine H3 receptor), Histamine H3 receptor (H3R).
Targets
H3 receptor · H3 receptor (histamine H3 receptor) · Histamine H3 receptor (H3R)
Phase 3 pipeline (6)
- Double-blind pitolisant · Harmony Biosciences Management, Inc. · Neurology
Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain. - Pitolisant tablet · Harmony Biosciences Management, Inc. · Neurology
Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness. - BF2.649 · Bioprojet · Neurology
BF2.649 is a histamine H3 receptor antagonist that increases histamine signaling in the brain to promote wakefulness and cognitive function. - Open-label pitolisant · Harmony Biosciences Management, Inc. · Neurology
Pitolisant is a selective histamine H3 receptor antagonist that increases wakefulness by blocking inhibitory histamine signaling in the brain. - BF2.649 add on Modafinil · Bioprojet · Neurology / Sleep Medicine
BF2.649 is a histamine H3 receptor antagonist that enhances wakefulness and cognitive function when combined with modafinil's dopamine/norepinephrine reuptake inhibition. - BF2.649 (pitolisant) · Bioprojet · Neurology
Pitolisant is a selective histamine H3 receptor antagonist that increases histamine release in the brain to promote wakefulness.
Patent intelligence
- histamine h3 receptor antagonist patent landscape — aggregated cliff calendar, attackable patents, originator estates